Infertility — Knowledge and Attitude Towards Fertility Among Emirati Infertile Patients
Citation(s)
Blair I, Sharif AA Population structure and the burden of disease in the United Arab Emirates. J Epidemiol Glob Health. 2012 Jun;2(2):61-71. doi: 10.1016/j.jegh.2012.04.002. Epub 2012 May 22.
Cramer DW, Walker AM, Schiff I Statistical methods in evaluating the outcome of infertility therapy. Fertil Steril. 1979 Jul;32(1):80-6.
Green KE, Smith DE Change and continuity: childbirth and parenting across three generations of women in the United Arab Emirates. Child Care Health Dev. 2007 May;33(3):266-74. doi: 10.1111/j.1365-2214.2006.00667.x.
Haynes, D (2016). ScholarWorks Delaying First Pregnancies: Canadian Women' s Knowledge and Perception of the Consequences. https://scholarworks.waldenu.edu/dissertations
Richardson SJ, Senikas V, Nelson JF Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987 Dec;65(6):1231-7. doi: 10.1210/jcem-65-6-1231.
Knowledge and Attitude Towards Fertility Among Emirati Infertile Patients
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
